Mayo Clinic Report Questions Financial Link between Avandia® Makers and Researchers
A Mayo Clinic study of researchers looking into a possible link between the diabetes drug Avandia® (rosiglitazone) and heart disease found that most of those whose study results did not support such a link had financial ties to the pharmaceutical industry.